Sulfonamide inhibitors: a patent review 2013-present

İ Gulçin, P Taslimi - Expert opinion on therapeutic patents, 2018 - Taylor & Francis
Introduction: Sulfonamide compounds are significant class of synthetic bacteriostatic
antibiotics still which used today for the therapy of bacterial infections and those caused by …

In vitro methods for testing antiviral drugs

M Rumlová, T Ruml - Biotechnology advances, 2018 - Elsevier
Despite successful vaccination programs and effective treatments for some viral infections,
humans are still losing the battle with viruses. Persisting human pandemics, emerging and …

A structural view on medicinal chemistry strategies against drug resistance

S Agnello, M Brand, MF Chellat… - Angewandte Chemie …, 2019 - Wiley Online Library
The natural phenomenon of drug resistance is a widespread issue that hampers the
performance of drugs in many major clinical indications. Antibacterial and antifungal drugs …

A phenoxy-bridged trinuclear Ni (II) complex: synthesis, structural elucidation and molecular docking with viral proteins

S Kumar, M Choudhary - New Journal of Chemistry, 2023 - pubs.rsc.org
A novel phenoxy-bridged trinuclear nickel (II) complex [Ni3 (μ-L) 2 (bipy) 3](1)(where
H3L=(E)-2-hydroxy-N-(2-hydroxy-3, 5-diiodophenyl)-3, 5-diiodobenzohydrazonic acid, bipy …

Phytochemical conjugation as a potential semisynthetic approach toward reactive and reuse of obsolete sulfonamides against pathogenic bacteria

SS Swain, SK Paidesetty… - Drug Development …, 2021 - Wiley Online Library
The emergence and reemergence of multidrug‐resistant (MDR) bacteria and mycobacteria
in community and hospital periphery have directly enhanced the hospitalization costs …

Design and synthesis of piperazine sulfonamide cores leading to highly potent HIV-1 protease inhibitors

CJ Bungard, PD Williams, J Schulz… - ACS medicinal …, 2017 - ACS Publications
Using the HIV-1 protease binding mode of MK-8718 and PL-100 as inspiration, a novel
aspartate binding bicyclic piperazine sulfonamide core was designed and synthesized. The …

Antivirals for broader coverage against human coronaviruses

M Outteridge, CM Nunn, K Devine, B Patel, GR McLean - Viruses, 2024 - mdpi.com
Coronaviruses (CoVs) are enveloped positive-sense single-stranded RNA viruses with a
genome that is 27–31 kbases in length. Critical genes include the spike (S), envelope (E) …

Leishmanicidal therapy targeted to parasite proteases

P de Almeida Machado, MPD Carneiro… - Life sciences, 2019 - Elsevier
Leishmaniasis is considered a serious public health problem and the current available
therapy has several disadvantages, which makes the search for new therapeutic targets and …

Pocket-to-Lead: Structure-Based De Novo Design of Novel Non-peptidic HIV-1 Protease Inhibitors Using the Ligand Binding Pocket as a Template

E Kojima, A Iimuro, M Nakajima, H Kinuta… - Journal of Medicinal …, 2022 - ACS Publications
A novel strategy for lead identification that we have dubbed the “Pocket-to-Lead” strategy is
demonstrated using HIV-1 protease as a model target. Sometimes, it is difficult to obtain hit …

Design strategies in the prodrugs of HIV-1 protease inhibitors to improve the pharmaceutical properties

MAM Subbaiah, NA Meanwell, JF Kadow - European journal of medicinal …, 2017 - Elsevier
Combination antiretroviral therapy (cART) is currently the most effective treatment for HIV-1
infection. HIV-1 protease inhibitors (PIs) are an important component of some regimens of …